Spectroscopy and Spectral Analysis, Volume. 41, Issue 2, 400(2021)

Data Augmentation of Raman Spectral and Its Application Research Based on DCGAN

Ling-qiao LI1,1, Yan-hui LI1,1、*, Lin-lin YIN1,1, Hui-hua YANG1,1, Yan-chun FENG1,1, Li-hui YIN1,1, and Chang-qin HU1,1
Author Affiliations
  • 1[in Chinese]
  • 11. School of Artificial Intelligence, Beijing University of Posts and Telecommunications, Beijing 100876, China
  • show less
    Figures & Tables(16)
    Diagram of DCGAN network structure for Raman spectrum classification
    Spectral augmentation by slope-bias adjusting
    Spectral generation by data augmentation
    The original spectra (a) were compared with the generated spectra (b) of DCGAN
    Comparison of classification accuracy of training set and test set
    • Table 1. CNN network design

      View table
      View in Article

      Table 1. CNN network design

      网络层设置参数
      INPUT预处理后的拉曼光谱数据
      Conv1Size: 1×5, stride: 1, ReLU
      Conv2Size: 1×5, stride: 1, ReLU
      Full ConnectedConv2的feature展开
      OUTPUT9个输出神经元, 连接FC层
    • Table 2. Generator network and Discriminator network for Raman spectral augmentation

      View table
      View in Article

      Table 2. Generator network and Discriminator network for Raman spectral augmentation

      生成网络判别网络
      网络层卷积核stridepadding激活函数BN层网络层卷积核stridepadding激活函数BN层
      deconv11×400ReLUconv11×521LeakyReLU
      deconv21×521ReLUconv21×421LeakyReLU
      deconv31×421ReLUconv31×421LeakyReLU
      deconv41×421ReLUconv41×421LeakyReLU
      deconv51×421ReLUconv51×521LeakyReLU
    • Table 3. Distribution of corresponding drugs in data set National Institute for Food and Drug Control

      View table
      View in Article

      Table 3. Distribution of corresponding drugs in data set National Institute for Food and Drug Control

      序号药品类别样本数目
      1Gatifloxacin15
      2Lomefloxacin21
      3Norfloxacin15
      4Pefloxacin12
      5Cephradine18
      6Cefradline15
      7Cefixime9
      8Ceftazidime18
      9Cefdinir30
    • Table 4. The training set, test set distribution of drug samples

      View table
      View in Article

      Table 4. The training set, test set distribution of drug samples

      药品训练集测试集
      Gatifloxacin114
      Lomefloxacin156
      Norfloxacin114
      Pefloxacin93
      Cephradine135
      Cefradline114
      Cefixime72
      Ceftazidime135
      Cefdinir219
      总数11152
    • Table 5. Detailed results of Raman spectrum discrimination of China food and drug institute-SVM (%)

      View table
      View in Article

      Table 5. Detailed results of Raman spectrum discrimination of China food and drug institute-SVM (%)

      药品分错数量
      训练集测试集
      Gatifloxacin53
      Lomefloxacin42
      Norfloxacin42
      Pefloxacin73
      Cephradine43
      Cefradline53
      Cefixime62
      Ceftazidime44
      Cefdinir23
      分类准确率63.06(70/111)51.92(27/52)
    • Table 6. Detailed results of Raman spectrum discrimination CNN (%)

      View table
      View in Article

      Table 6. Detailed results of Raman spectrum discrimination CNN (%)

      药品分错数量
      训练集测试集
      Gatifloxacin32
      Lomefloxacin21
      Norfloxacin22
      Pefloxacin42
      Cephradine21
      Cefradline32
      Cefixime52
      Ceftazidime21
      Cefdinir10
      分类准确率78.38(87/111)75.00(39/52)
    • Table 7. The training set, test set distribution of drug samples

      View table
      View in Article

      Table 7. The training set, test set distribution of drug samples

      药品训练集测试集
      Gatifloxacin7030
      Lomefloxacin7030
      Norfloxacin7030
      Pefloxacin7030
      Cephradine7030
      Cefradline7030
      Cefixime7030
      Ceftazidime7030
      Cefdinir7030
      总数630270
    • Table 8. Detailed results of Raman spectrum discrimination of China food and drug institute-Data augmentation and CNN (%)

      View table
      View in Article

      Table 8. Detailed results of Raman spectrum discrimination of China food and drug institute-Data augmentation and CNN (%)

      药品分错数量
      训练集测试集
      Gatifloxacin91
      Lomefloxacin53
      Norfloxacin82
      Pefloxacin102
      Cephradine42
      Cefradline84
      Cefixime71
      Ceftazidime83
      Cefdinir74
      分类准确率89.52(564/630)91.85(248/270)
    • Table 9. LVE signal to noise ratio of augmented spectral by slope-bias adjusting (corresponding to Fig.3)

      View table
      View in Article

      Table 9. LVE signal to noise ratio of augmented spectral by slope-bias adjusting (corresponding to Fig.3)

      原始谱图(a)扩增谱图(b)
      24.5631.24
      29.74
      30.18
      32.05
      31.77
      34.65
      28.47
      30.69
      29.69
      31.51
    • Table 10. Detailed results of Raman spectrum discrimination of DCGAN and CNN (%)

      View table
      View in Article

      Table 10. Detailed results of Raman spectrum discrimination of DCGAN and CNN (%)

      药品分错数量
      训练集测试集
      Gatifloxacin31
      Lomefloxacin40
      Norfloxacin22
      Pefloxacin30
      Cephradine10
      Cefradline30
      Cefixime20
      Ceftazidime30
      Cefdinir21
      分类准确率96.3598.52
    • Table 11. LVE signal to noise ratio of augmented spectral by DCGAN (corresponding to Fig.4)

      View table
      View in Article

      Table 11. LVE signal to noise ratio of augmented spectral by DCGAN (corresponding to Fig.4)

      原始谱图(a)扩增谱图(b)
      27.6729.28
      27.0830.59
      28.6531.63
      20.4931.79
      29.0132.02
      27.5331.67
      20.6529.28
      28.2229.32
      21.5630.37
      20.8629.34
    Tools

    Get Citation

    Copy Citation Text

    Ling-qiao LI, Yan-hui LI, Lin-lin YIN, Hui-hua YANG, Yan-chun FENG, Li-hui YIN, Chang-qin HU. Data Augmentation of Raman Spectral and Its Application Research Based on DCGAN[J]. Spectroscopy and Spectral Analysis, 2021, 41(2): 400

    Download Citation

    EndNote(RIS)BibTexPlain Text
    Save article for my favorites
    Paper Information

    Category: Research Articles

    Received: Feb. 5, 2020

    Accepted: Jun. 2, 2020

    Published Online: Apr. 8, 2021

    The Author Email: LI Yan-hui (1703201023@mails.guet.edu.cn)

    DOI:10.3964/j.issn.1000-0593(2021)02-0400-08

    Topics